TriNetX Acquires Pharmacovigilance Leader Advera Health Analytics

Jan 21, 2022 | Press Releases

The world’s largest real-world data network takes aim at improving drug safety Cambridge, MA, January 21, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the...

TriNetX Launches Machine Learning Capabilities on Global Real-World Data

Jan 6, 2022 | Press Releases

Cambridge, MA, January 6, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of its Bring Your Own Model (BYOM) product, a major step forward for the...

TriNetX Launches Diversity Lens Analytic to Improve Access to Clinical Trials for Underrepresented Patient Populations

Dec 9, 2021 | Press Releases

Cambridge, MA, December 9, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of Diversity Lens, an analytic feature on the TriNetX platform which helps...

TriNetX and Advarra Partner to Provide Enhanced Site Selection Services

Nov 16, 2021 | Press Releases

Cambridge, MA, November 16, 2021 — TriNetX, the global health research network; and Advarra, the premier provider of independent review committees, quality and compliance consulting services, and research technology solutions; today announced a partnership that will...

TriNetX Announces the Appointment of Dr. Jeffrey Brown as Chief Scientific Officer

Nov 1, 2021 | Press Releases

Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining the company as Chief Scientific Officer (CSO). Dr....

Colombia’s Clínica Imbanaco Joins the TriNetX Network to Increase International Research Collaboration

Oct 8, 2021 | Press Releases

Cambridge, MA, October 8, 2021 — Clínica Imbanaco, a leading research organization in Colombia, has joined the TriNetX network to maximize its research capacity and to expand its collaboration with other research sites around the world. Headquartered in Cali,...

Leading Cancer Center in France, L’Institut de Cancérologie de l’Ouest (ICO), Joins the TriNetX Network to Strengthen Research Capabilities

Sep 27, 2021 | Press Releases

St Herblain, France, September 27, 2021 — L’Institut de Cancérologie de l’Ouest (ICO), one of the leading provincial cancer centers in France, has joined the TriNetX global health research network to facilitate innovative patient care, promote clinical...

Unlocking the Value of Genotypic and Phenotypic Data for Translational Research

Aug 24, 2021 | Blog

The advent of precision medicine is revolutionizing diagnostics and treatment across a broad range of illnesses. Genetic biomarkers are increasingly using DNA, RNA and protein sequencing results, and are an integral part of the precision medicine revolution and...

Why Using Real-World Data Internally During Clinical Trial Design is a Must for Every Sponsor

Aug 4, 2021 | Blog

A family member of mine had exhausted all his available options in his battle with cancer. There was one experimental drug that we believed would help him one last time, but his lab values were not high (sick) enough to meet the eligibility criteria for the trial. So,...

Marshfield Clinic Research Institute Joins TriNetX to Increase Participation in High-Impact Clinical Trial Opportunities

Jul 26, 2021 | Press Releases

Cambridge, MA, July 26, 2021 — The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural...